World first as MHRA approves trofolastat for diagnostic imaging of prostate cancer in men
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeti...
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeti...
Read More
Other Stories in Health
- World first as MHRA approves trofolastat for diagnostic imaging of prostate cancer in men
- Who is Dr. Peter Marks? Why is the top vaccine official resigning from the FDA?
- Pull Meet With My Son
- Why Hypothyroidism Symptoms Worsen In Cold Winter Weather
- Six promising biomarkers could improve early and accurate detection of kidney injury
- Studies explore bioactive compounds in plants for disease prevention
- Top FDA vaccine official Peter Marks resigns in opposition to RFK Jr.
- Breakthrough discovery could lead to new class of antibiotics
- Cell's stress response is more nuanced and compartmentalized than previously thought
.png)
